Qyuns Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	961.75	360.69	216.3	213.09	218.06
Short-Term Investments	80.86	0.42	0.54	0.55	0.29
Trading Asset Securities	-	195.44	160.41	401.1	402.38
Cash & Short-Term Investments	1,043	556.55	377.26	614.73	620.72
Cash Growth	87.33%	47.53%	-38.63%	-0.97%	-
Accounts Receivable	19.7	26.28	-	-	-
Other Receivables	0.18	0.6	0.36	4.04	8.65
Receivables	19.87	26.88	0.36	4.04	8.65
Inventory	8.45	3.34	3.77	-	-
Prepaid Expenses	16.13	24.52	23.03	16.23	18.45
Other Current Assets	29.61	5.44	13.91	0.94	0.44
Total Current Assets	1,117	616.73	418.33	635.95	648.26
Property, Plant & Equipment	309.83	334.06	361.44	386.16	400.83
Long-Term Investments	134.86	-	-	-	-
Other Intangible Assets	2.46	3.47	2.35	3.05	0.38
Other Long-Term Assets	36.51	29.62	13.47	9.94	18.02
Total Assets	1,600	983.88	795.58	1,035	1,067
Accounts Payable	96.72	110.89	72.96	19.14	12.6
Accrued Expenses	43.79	33.37	31.01	24.64	19.04
Short-Term Debt	29.8	179.48	59.6	15.9	-
Current Portion of Long-Term Debt	148.15	31.1	60.1	44.61	14.87
Current Portion of Leases	1.27	1.42	1.29	1.75	0.96
Current Unearned Revenue	44.53	9.36	0.87	-	-
Other Current Liabilities	139.48	64.54	25.95	16.15	22.22
Total Current Liabilities	503.74	430.16	251.78	122.19	69.67
Long-Term Debt	399.45	315.12	224.43	232.52	274.05
Long-Term Leases	1.34	0.47	0.63	0.47	0.39
Long-Term Unearned Revenue	16.44	16.73	17.38	18.02	18.66
Long-Term Deferred Tax Liabilities	0.27	0.34	0.41	0.49	0.56
Total Liabilities	921.23	762.83	494.63	373.69	363.33
Common Stock	227.07	222.07	210.03	180.53	166.48
Additional Paid-In Capital	-	1,012	830.18	830.18	616.23
Retained Earnings	-	-1,257	-921.36	-413.61	-115.42
Comprehensive Income & Other	466.96	251.37	175.91	44.62	3.06
Total Common Equity	694.03	228.98	294.76	641.72	670.35
Minority Interest	-14.93	-7.93	6.19	19.7	33.82
Shareholders' Equity	679.1	221.05	300.95	661.41	704.17
Total Liabilities & Equity	1,600	983.88	795.58	1,035	1,067
Total Debt	580.01	527.6	346.06	295.25	290.26
Net Cash (Debt)	462.6	28.96	31.2	319.48	330.46
Net Cash Growth	1497.61%	-7.18%	-90.23%	-3.32%	-
Net Cash Per Share	2.07	0.13	0.15	1.80	2.84
Filing Date Shares Outstanding	225.56	222.07	222.07	180.53	166.48
Total Common Shares Outstanding	225.56	222.07	210.03	180.53	166.48
Working Capital	612.93	186.56	166.55	513.76	578.59
Book Value Per Share	3.08	1.03	1.40	3.55	4.03
Tangible Book Value	691.57	225.5	292.42	638.66	669.98
Tangible Book Value Per Share	3.07	1.02	1.39	3.54	4.02
Buildings	-	238.61	238.73	238.73	238.73
Machinery	-	190.77	188.24	178.24	168.09
Construction In Progress	-	0.43	0.21	4.96	2.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.